ESTRELLA IMMUNOPHARMA, INC. (ESLA) Free cash flow
ESTRELLA IMMUNOPHARMA, INC. (ESLA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to ESLASource: SEC XBRL filings · For reference only · Not investment advice
More ESLA financial trends
ESLA RevenueESLA Net incomeESLA Net marginESLA Gross profitESLA Gross marginESLA Operating incomeESLA Operating marginESLA Operating cash flowESLA Capital expendituresESLA Return on equityESLA Stock buybacksESLA Dividends paidESLA Total assetsESLA Total liabilitiesESLA Shareholders’ equityESLA overview →